Bimal Shah
Directeur/Bestuurslid bij ANEBULO PHARMACEUTICALS, INC.
Profiel
Bimal R.
Shah currently works at Anebulo Pharmaceuticals, Inc., as Independent Director from 2023 and Allos Therapeutics, Inc., as Chief Financial Officer & Treasurer from 2012.
Mr. Shah also formerly worked at Spectrum Pharmaceuticals, Inc., as Vice President-Corporate & Business Development from 2013 to 2021.
Mr. Shah received his undergraduate degree, graduate degree, and Masters Business Admin degree from Stanford University.
Actieve functies van Bimal Shah
| Bedrijven | Functie | Begin |
|---|---|---|
| ANEBULO PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 05-10-2023 |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Financieel Directeur/CFO | 05-09-2012 |
Eerdere bekende functies van Bimal Shah
| Bedrijven | Functie | Einde |
|---|---|---|
| SPECTRUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-01-2021 |
Opleiding van Bimal Shah
| Stanford University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| SPECTRUM PHARMACEUTICALS, INC. | Health Technology |
| ANEBULO PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Allos Therapeutics, Inc.
Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Health Technology |
